TRK Inhibitors: A Tumor Agnostic Targeted Therapy

June 25th 2018

Inside the Clinic: Interdisciplinary Care for Stage IV NSCLC

May 25th 2018

New Treatment Strategies for Hepatocellular Carcinoma

April 24th 2018

Antiangiogenic Therapy in the Current Landscape of NSCLC

April 19th 2018

Treatment Updates in Chronic Lymphocytic Leukemia

March 31st 2018

Treatment Strategies in Neuroendocrine Tumors

March 1st 2018

Sequencing Strategies: Metastatic Pancreatic Adenocarcinoma

February 27th 2018

Balancing Efficacy and Quality of Life in Refractory CRC

February 17th 2018

New Concepts: Multimodal Approaches to Advanced NSCLC

January 30th 2018

New Treatment Strategies for Follicular Lymphoma

January 23rd 2018

Treatment of Nonmetastatic Castration-Resistant Prostate Cancer

December 28th 2017

Checkpoint Inhibitors in Advanced Bladder Cancer

December 28th 2017

Managing Treatment Decisions for Ovarian Cancer

December 23rd 2017

Updates in Advanced Gastric/GEJ Cancer Treatment

December 22nd 2017

Case-Based Insights on Multiple Myeloma

December 8th 2017

The Evolving Role of PARP Inhibitors in Ovarian Cancer

November 20th 2017

Collaborative Care in Soft Tissue Sarcoma

November 14th 2017

CDK4/6 Inhibitors for Hormone-Driven Breast Cancer

October 2nd 2017

Addressing Unmet Needs in Liver Cancer

September 8th 2017

Liquid Biopsy Use in Metastatic Non-Small Cell Lung Cancer

August 29th 2017